Association between Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers and Lung Cancer
- 1 September 2021
- journal article
- research article
- Published by Southern Medical Association in Southern Medical Journal
- Vol. 114 (9), 607-613
- https://doi.org/10.14423/smj.0000000000001293
Abstract
Objectives: Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) are the most commonly prescribed antihypertensives, with prior studies identifying a possible association between long-term use and increased rates of lung cancer. This study evaluated this potential association in a large population using propensity matching. Methods: This was a...Keywords
This publication has 30 references indexed in Scilit:
- A Meta-Analysis Reporting Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patients Without Heart FailureJournal of Invasive Cardiology, 2013
- Long-Term Use of Angiotensin Receptor Blockers and the Risk of CancerPLOS ONE, 2012
- Long term use of drugs affecting the renin‐angiotensin system and the risk of cancer: a population‐based case‐control studyBritish Journal of Clinical Pharmacology, 2012
- Use of Angiotensin Receptor Blockers and the Risk of CancerJournal of the American College of Cardiology, 2011
- Angiotensin inhibition and malignancies: a reviewJournal of Human Hypertension, 2009
- Captopril as a Potential Inhibitor of Lung Tumor Growth and MetastasisAnnals of the New York Academy of Sciences, 2008
- Antihypertensive medication and their impact on cancer incidence: a mixed treatment comparison meta-analysis of randomized controlled trialsJournal of Hypertension, 2008
- Angiotensin receptors: a new role in cancer?Trends in Endocrinology & Metabolism, 2005
- Angiotensin converting enzyme inhibitors for cancer treatment?Acta Oncologica, 2004
- Differential regulation of in vivo angiogenesis by angiotensin II receptorsThe FASEB Journal, 2003